The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Clinical trial NCT02477748 · TERMINATED

Trial details

NCT number: NCT02477748
Sponsor: Alcobra Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)

Start date: 2015-06-01
Primary completion: 2017-01-01
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.